🚀 VC round data is live in beta, check it out!
Sinohealth Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sinohealth and similar public comparables like SOPHiA Genetics, Kneat, Echo IQ, Cogstate and more.
Sinohealth Overview
About Sinohealth
Sinohealth Holdings Ltd operates in the healthcare industry. It offers digital and intelligent solutions that include AI agent applications tailored for healthcare, pharmacies, business, health management, and Research and Development. The company offers various digital solutions, such as the Intelligent Retail Cloud, Intelligent Medical Cloud, Intelligent Health Management Cloud, and various other data insights and Software as a Service (Saas) products for different domains in the healthcare industry. Geographically, the company generates maximum revenue from Mainland China, followed by, Netherlands, England, Hong Kong, Singapore, and other regions.
Founded
2019
HQ
Employees
768
Website
Financials (FY)
EV
$283M
Sinohealth Financials
Sinohealth reported last fiscal year revenue of $59M and EBITDA of $19M.
In the same fiscal year, Sinohealth generated $34M in gross profit, $19M in EBITDA, and $16M in net income.
Sinohealth P&L
In the most recent fiscal year, Sinohealth reported revenue of $59M and EBITDA of $19M.
Sinohealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $59M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $34M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 58% | XXX | XXX | XXX |
| EBITDA | — | XXX | $19M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 32% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 26% | XXX | XXX | XXX |
| Net Profit | — | XXX | $16M | XXX | XXX | XXX |
| Net Margin | — | XXX | 27% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sinohealth Stock Performance
Sinohealth has current market cap of $283M, and enterprise value of $283M.
Market Cap Evolution
Sinohealth's stock price is $0.69.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $283M | $283M | 0.0% | XXX | XXX | XXX | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSinohealth Valuation Multiples
Sinohealth trades at 4.8x EV/Revenue multiple, and 15.1x EV/EBITDA.
Sinohealth Financial Valuation Multiples
As of March 7, 2026, Sinohealth has market cap of $283M and EV of $283M.
Equity research analysts estimate Sinohealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sinohealth has a P/E ratio of 17.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $283M | XXX | $283M | XXX | XXX | XXX |
| EV (current) | $283M | XXX | $283M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 4.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 15.1x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 19.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 8.4x | XXX | XXX | XXX |
| P/E | — | XXX | 17.6x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 22.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sinohealth Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sinohealth Margins & Growth Rates
Sinohealth's revenue in the last fiscal year grew by 2%.
Sinohealth Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 7% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 16% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sinohealth Public Comps
See public comps and valuation multiples for other Health Data & Analytics and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| SOPHiA Genetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Kneat | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
| National Research | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sinohealth M&A Activity
Sinohealth acquired XXX companies to date.
Last acquisition by Sinohealth was on XXXXXXXX, XXXXX. Sinohealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sinohealth
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSinohealth Investment Activity
Sinohealth invested in XXX companies to date.
Sinohealth made its latest investment on XXXXXXXX, XXXXX. Sinohealth invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sinohealth
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sinohealth
| When was Sinohealth founded? | Sinohealth was founded in 2019. |
| Where is Sinohealth headquartered? | Sinohealth is headquartered in China. |
| How many employees does Sinohealth have? | As of today, Sinohealth has over 768 employees. |
| Is Sinohealth publicly listed? | Yes, Sinohealth is a public company listed on HKEX. |
| What is the stock symbol of Sinohealth? | Sinohealth trades under 02361 ticker. |
| When did Sinohealth go public? | Sinohealth went public in 2022. |
| Who are competitors of Sinohealth? | Sinohealth main competitors are SOPHiA Genetics, Kneat, Echo IQ, Cogstate. |
| What is the current market cap of Sinohealth? | Sinohealth's current market cap is $283M. |
| What is the current revenue of Sinohealth? | Sinohealth's last fiscal year revenue is $59M. |
| What is the current EV/Revenue multiple of Sinohealth? | Current revenue multiple of Sinohealth is 4.8x. |
| Is Sinohealth profitable? | No, Sinohealth is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.